3 documents found, page 1 of 1
CheckAP
Oliveira Henriques, Ana Rita; M. Pimentel-Santos, F.; Teles de Sousa, João; Silva, Leandro; Gago, Laura; Santos, Mariana Emília; Teodósio Chícaro, AnaPublisher Copyright: © 2024, Sociedade Portuguesa de Reumatologia. All rights reserved.; Background: The percentage of Portuguese psoriasis patients with psoriatic arthritis is unknown but musculoskeletal complaints related to PsA affect up to a third of patients. Dermatologists can identify early PsA as skin symptoms often precede joint symptoms in 80% of patients. Efficient and easy to perform screening tools...
Effectiveness of switching between TNF inhibitors in patients with axial spondy...
Rodrigues Manica, Santiago; Sepriano, Alexandre; M. Pimentel-Santos, F.; Gouveia, Nélia; Barcelos, Anabela; Branco, Jaime; Bernardes, Miguel57763]. AS is supported by a doctoral grant from “Fundação para a Ciência e Tecnologia” (SFRH/BD/108246/2015).; Background: To investigate whether the reason to discontinue the first TNF inhibitor (TNFi) affects the response to the second TNFi in axial spondyloarthritis (axSpA). Methods: Patients with axSpA from the Rheumatic Diseases Portuguese Register (ReumaPt), who discontinued their first TNFi and started ...
Portuguese recommendations for the use of methotrexate in rheumatic diseases - ...
Duarte, Ana Catarina; Santos-Faria, Daniela; Gonçalves, Maria João; Sepriano, Alexandre; Mourão, Ana Filipa; Duarte, Cátia; Neves, Joana SousaBACKGROUND: Methotrexate (MTX) is the first-line drug in the treatment of rheumatoid arthritis (RA) and the most commonly prescribed disease modifying anti-rheumatic drug. Moreover, it is also used as an adjuvant drug in patients under biologic therapies, enhancing the efficacy of biologic agents. OBJECTIVES: To review the literature and update the Portuguese recommendations for the use of MTX in rheumatic dise...